Brain-Computer Interface Unicorn Ladder Medical Completes 500 Million Yuan Financing

On March 13th, reporters learned that the domestic brain-computer interface startup Ladder Medical recently completed a strategic financing of 500 million yuan, led by Alibaba, with Guotou Chuanghe participating as a co-investor. Existing shareholders Tencent, Yuanlai Capital, Aobo Capital, Yuanhe Yuan Dian, Qiming Venture Partners, Eli Lilly Asia Fund, Source Code Capital, and Shanghai Guotou Xian Dao continued to participate, with Qifeng Capital serving as the exclusive financial advisor. Ladder Medical has raised over 1.1 billion yuan in total funding within the past year, making it the first company in the brain-computer interface field to be involved in plans by Alibaba and Tencent. The reporter learned that Ladder Medical plans to conduct large-scale, multi-center registration clinical trials by mid-2026, aiming to enroll and implant approximately 40 patients within the year. Ladder Medical expects that by the end of 2026, its total number of clinical implants could approach or even surpass the current approximately 21 clinical trials of Neuralink, Elon Musk’s brain-computer interface company. (Interface)